Correlation Between NLS Pharmaceutics and NLS Pharmaceutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NLS Pharmaceutics and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NLS Pharmaceutics and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NLS Pharmaceutics AG and NLS Pharmaceutics AG, you can compare the effects of market volatilities on NLS Pharmaceutics and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NLS Pharmaceutics with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NLS Pharmaceutics and NLS Pharmaceutics.

Diversification Opportunities for NLS Pharmaceutics and NLS Pharmaceutics

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between NLS and NLS is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding NLS Pharmaceutics AG and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and NLS Pharmaceutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NLS Pharmaceutics AG are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of NLS Pharmaceutics i.e., NLS Pharmaceutics and NLS Pharmaceutics go up and down completely randomly.

Pair Corralation between NLS Pharmaceutics and NLS Pharmaceutics

Assuming the 90 days horizon NLS Pharmaceutics AG is expected to generate 4.95 times more return on investment than NLS Pharmaceutics. However, NLS Pharmaceutics is 4.95 times more volatile than NLS Pharmaceutics AG. It trades about 0.06 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about -0.25 per unit of risk. If you would invest  1.20  in NLS Pharmaceutics AG on September 3, 2024 and sell it today you would lose (0.20) from holding NLS Pharmaceutics AG or give up 16.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

NLS Pharmaceutics AG  vs.  NLS Pharmaceutics AG

 Performance 
       Timeline  
NLS Pharmaceutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in NLS Pharmaceutics AG are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, NLS Pharmaceutics showed solid returns over the last few months and may actually be approaching a breakup point.
NLS Pharmaceutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NLS Pharmaceutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

NLS Pharmaceutics and NLS Pharmaceutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NLS Pharmaceutics and NLS Pharmaceutics

The main advantage of trading using opposite NLS Pharmaceutics and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NLS Pharmaceutics position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.
The idea behind NLS Pharmaceutics AG and NLS Pharmaceutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Transaction History
View history of all your transactions and understand their impact on performance